Moomoo AI 已提取核心信息
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 6,095 shares of common stock on March 4, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $9,310.72. Following the sale, Obenshain's direct holdings in the company amount to 279,998 shares of common stock.
Andrew Obenshain, President and CEO of bluebird bio, Inc., completed a sale of 6,095 shares of common stock on March 4, 2024. The transaction was carried out in the open market with the shares sold at a price of $1.5276 each, resulting in a total sale value of $9,310.72. Following the sale, Obenshain's direct holdings in the company amount to 279,998 shares of common stock.
蓝鸟生物公司总裁兼首席执行官安德鲁·奥本沙因于2024年3月4日完成了6,095股普通股的出售。该交易在公开市场上进行，股票以每股1.5276美元的价格出售，总销售价值为9,310.72美元。出售后，Obenshain在该公司的直接持有量为279,998股普通股。
蓝鸟生物公司总裁兼首席执行官安德鲁·奥本沙因于2024年3月4日完成了6,095股普通股的出售。该交易在公开市场上进行，股票以每股1.5276美元的价格出售，总销售价值为9,310.72美元。出售后，Obenshain在该公司的直接持有量为279,998股普通股。
有用
没用